MIST Stock Summary and Trading Ideas (Milestone Pharmaceuticals - Common Shares | NASDAQ:MIST)

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Milestone Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol MIST.

As of July 15, 2026, MIST stock price declined to $1.27 with 753,848 million shares trading.

MIST has a beta of 3.68, meaning it tends to be more sensitive to market movements. MIST has a correlation of 0.28 to the broad based SPY ETF.

MIST has a market cap of $158.11 million. This is considered a Micro Cap stock.

Last quarter Milestone Pharmaceuticals - Common Shares reported $238,000 in Revenue and -$.20 earnings per share. This fell short of revenue expectation by $-45 million and missed earnings estimates by -$.34.

In the last 3 years, MIST traded as high as $3.62 and as low as $.63.

The top ETF exchange traded funds that MIST belongs to (by Net Assets): GWX.

MIST has underperformed the market in the last year with a price return of -8.0% while the SPY ETF gained +22.0%. MIST has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -37.4% and -5.2%, respectively, while the SPY returned +9.0% and +1.1%, respectively.

MIST support price is $1.25 and resistance is $1.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MIST shares will trade within this expected range on the day.